Transfusion-Associated Immunomodulation: Experimental Facts and Clinical Reality – New Perspectives
Open Access
- 21 July 2006
- journal article
- Published by S. Karger AG in Transfusion Medicine and Hemotherapy
- Vol. 33 (4), 324-329
- https://doi.org/10.1159/000092261
Abstract
Blood component transfusion may be required in association with emergency and chronic disease to improve hemodynamics and tissue oxygenation. Due to the risk of microbial transfection from donor to recipient, the blood is undergoing vigorous testing to improve safety. It is well known, however, that blood component transfusion may lead to certain acute side effects with a frequency of 0.5-2% depending on the specific component transfused. In addition, homologous blood component transfusion seems to be associated with increased frequency of bacterial infectious complication after operation in a variety of diseases. If patients have been operated on for malignant diseases, emerging evidence has accumulated that suggests a combination of blood component transfusion, postoperative bacterial infectious complications and subsequent poor longterm survival even in patients who have been curatively resected. The mechanisms leading to such side effects are not known in detail, but bioactive substance accumulation during preparation and storage may play an important role. Such substances may also explain why side effects are also observed after autologous blood transfusion. Institution of universal leukofiltration in most European countries has led to improvement in patient treatment, with reduction of a variety of side effects. Future research should be focused on patient genetic polymorphisms that may play a role in the development of side effects to blood component transfusion.Keywords
This publication has 71 references indexed in Scilit:
- Impact of elective resection on plasma TIMP‐1 levels in patients with colon cancerColorectal Disease, 2005
- Transplantation of organs is transplantations of donor DNA: fate of DNA disseminated in recipientTransplant International, 2005
- Improving Perioperative Outcome Expands the Role of Hepatectomy in Management of Benign and Malignant Hepatobiliary DiseasesAnnals of Surgery, 2004
- Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgeryBMJ, 2004
- Perioperative blood transfusions, with or without allogeneic leucocytes, relate to survival, not to cancer recurrenceBritish Journal of Surgery, 2001
- Prestorage leukocyte filtration may reduce leukocyte-derived bioactive substance accumulation in patients operated for burn traumaClinical Dermatology and Surgery, 1999
- Blood Transfusion at Delivery and Risk of Subsequent Malignant Lymphoma in the MotherVox Sanguinis, 1998
- Testing Blood Donors for HIV: Current ControversiesImmunological Investigations, 1995
- Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancerThe Lancet, 1994
- Cancer morbidity in blood recipients—Results of a cohort studyEuropean Journal of Cancer, 1993